ArticleESMO real world data and digital oncology2025

Association between neoadjuvant paclitaxel dose intensity and outcomes in early triple-negative and HER2-positive breast cancer: a real-world data analysis.

C van Marcke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.